China Cancer Drug Misuse In Spotlight After Shocking Whistleblower Tales
Guideline Non-Compliance, Off-Label Use
Using PD-1 immuno-oncology drugs to treat post-surgery gastric cancer and prescribing unapproved targeted therapies for colon cancer are just two examples of the apparently widespread misuse of oncology drugs in China, as alleged by an oncologist at a prestigious Peking university hospital.
